Diagnosing MASH (Liver Disease): A Meaningful Opportunity for Early Detection
Learn why addressing MASH, liver disease in an earlier stage, is crucial for improving patient outcomes and reducing healthcare costs.
Learn why addressing MASH, liver disease in an earlier stage, is crucial for improving patient outcomes and reducing healthcare costs.
Lisa Meyer MSN, RN, NI-BC, shares insights on improving patient throughput, tackling capacity challenges with early detection, and more.
Raghu Pillai shares how early disease detection impacts patient and provider engagement, plus insights on personalized care strategies.
Michelle Fortune shares valuable perspectives on the evolving landscape of cancer screening, the challenges of increased demand for screenings, and the important role of early disease detection in building long-term relationships with patients and families.
Alejandro Reti, MD, shares perspectives on managing long-term care costs, the importance of predictability in healthcare costs, and more.
Let's go beyond traditional health awareness efforts, like nostalgic billboards urging lung cancer screenings, to combat pervasive diseases.
Exploring recent developments for AFib management, from newly investigated pharmacological treatments to novel screening modalities.
Why early stroke detection matters, and the opportunity for provider organizations to improve both outcomes and financial yield.
Introducing Reveal for Lung Cancer, an advanced AI solution designed for earlier lung cancer detection that targets patients at higher risk.
Why the availability of clinical Artificial Intelligence (AI) solutions offers truly measurable gains to population health programs.